Sales rise 10.86% to Rs 502.45 crore
Net profit of Caplin Point Laboratories rose 17.25% to Rs 142.57 crore in the quarter ended March 2025 as against Rs 121.59 crore during the previous quarter ended March 2024. Sales rose 10.86% to Rs 502.45 crore in the quarter ended March 2025 as against Rs 453.22 crore during the previous quarter ended March 2024.For the full year,net profit rose 17.33% to Rs 536.31 crore in the year ended March 2025 as against Rs 457.09 crore during the previous year ended March 2024. Sales rose 14.37% to Rs 1937.47 crore in the year ended March 2025 as against Rs 1694.10 crore during the previous year ended March 2024.
ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales502.45453.22 11 1937.471694.10 14 OPM %33.4532.04 -33.3932.55 - PBDT193.71162.43 19 742.74617.87 20 PBT176.67146.03 21 676.78564.43 20 NP142.57121.59 17 536.31457.09 17
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
